Henry Schein, Inc. Acquires Leading Independent U.S. Vaccine Supplier - 1998 Sales of $118 Million -
Philip A. Laskawy
Philip A.
Laskawy
Lead Director, Henry Schein, Inc.; and Retired Chairman, EY LLP
Financial Expert